Aurobindo’s CuraTeQ Expands Biosimilars Deal With Orion For Baltic Countries

Partners Expect To Launch Products Between 2023 And 2026

Aurobindo’s CuraTeQ Biologics has expanded its biosimilar distribution agreement with Finnish Player Orion. After covering the Nordics, Austria, Hungary and Slovenia, the partnering companies have decided to expand to the Baltic countries, with launches slated for between 2023 and 2026.

Baltic Countries
After covering the Nordics, Austria, Hungary and Slovenia, the partnering companies will supply biosimilars to the Baltic countries. • Source: Alamy

Aurobindo Pharma USA Inc.’s CuraTeQ Biologics has announced extending its partnership with Orion Corporation to expand their biosimilar distribution agreement in Europe to the Baltic countries.

Finnish player Orion noted that all the products under the agreement were still in development or regulatory phases, with launches...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business